December 11, 2023: ASH 2023: microbiome-based therapy shows potential in graft-versus-host disease – EPR

Date : January 22, 2024

[image_with_animation image_url=”11766″ animation=”Fade In” hover_animation=”none” alignment=”center” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.europeanpharmaceuticalreview.com/news/189940/ash-2023-microbiome-based-therapy-shows-potential-in-graft-versus-host-disease/#:~:text=ASH%202023:%20microbiome-based%20therapy,in%20graft-versus-host%20disease&text=Data%20presented%20at%20the%202023,-host%20disease%20(GvHD)”]